4Geyer D,Gerrits MGF,Renoux A,et al.Pharmacokinetics of FEM(R)7,a once-weekly,transdermal oestrogen replacement system in healthy,postmenopansal women[J].Gynecologic and Obstetric Investigation,1999,48(1):1-6.
5Clarke SC,Kelleher J,Lloyd-Jones H,et al.A study of hormone replacement therapy in postmenopansal women with isehaemic heart disease:the Papworth HRT atherosclerosis study[J].BJOG,2002,109(9):1056-1062.
6Menon DV,Vongpatsnasin W.Effects of transdermal estrogen replacement therapy on cardiovascular risk factors[J].Treat Endocrinol,2006,5(1):37-51.
7Sumino H,Ichikawa S,Kasama S,et al.Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women[J].Atherosclerosis,2006,189(2):436-442.
8Ho JY,Chen MJ,Sheu WH,et al.Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women[J].Hum Reprod,2006,21(10):2715-2720.
9Vrablik M,Fait T,Kovar J,et al.Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins[J].Metabolism,2008,57(8):1088-1092.
10Canonico M,Oger E,Plu-Bureau G,et al.Hormone therapy and venou$thromboembolism among postmenopausal women:impact of the route of estrogen administration and progestogens:the ESTHER study[J].Circulation,2007,115(7):840-845.
